Clinical trial
Effect and Tolerability of Lactobacillus Rhamnosus GG LA801 for the Preventive Nutritional Care of Nosocomial Diarrhea in Children
NCT04628819 is registered in ClinicalTrials.gov with PiLeJe as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect and Tolerability of Lactobacillus Rhamnosus GG LA801 for the Preventive Nutritional Care of Nosocomial Diarrhea in Children
- Lead sponsor
- PiLeJe
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 29, 2019
- Completion date
- April 1, 2020
- Enrollment
- 61 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
diarrhea, infantile, nosocomial infection